NeurogesX, Inc. (NASDAQOTCBB:NGSX)

CAPS Rating: 1 out of 5

A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.

Results 1 - 1 of 1

Recs

0
Member Avatar siri22 (< 20) Submitted: 1/31/2012 12:59:38 AM : Outperform Start Price: $1.04 NGSX Score: -123.68

Junk

Report this Post Reply
Results 1 - 1 of 1

Featured Broker Partners


Advertisement